文献速递细菌感染、耐药与抗菌药物医院感染防控

结直肠手术预防用阿莫西林、甲硝唑和庆大霉素给药方案评估

Evaluation of amoxicillin, metronidazole and gentamicin dosage regimens for use in antibiotic prophylaxis in colorectal surgery.
PubMed 文献 · J Antimicrob Chemother · 2021-01-01

在20例结直肠手术患者中评估阿莫西林1000 mg、甲硝唑500 mg和庆大霉素3 mg/kg理想体重的预防给药方案,用NONMEM进行群体药代动力学分析并结合蒙特卡洛模拟估算PTA。结果显示所给剂量仅对咽峡炎链球菌组维持8小时PTA,对肠球菌、脆弱拟杆菌组、MSSA和大肠埃希菌未达标,模拟识别出可覆盖相关病原体的优化方案。

要点

  • 所给剂量对咽峡炎链球菌组维持8小时PTA,对肠球菌、脆弱拟杆菌组、MSSA和大肠埃希菌未达标。
  • 阿莫西林每4小时追加500 mg可覆盖多数相关病原体,感染性心内膜炎风险者需每2小时给药。
  • 体重>85 kg者甲硝唑需1000 mg;CLCR>50 mL/min者庆大霉素5 mg/kg可维持PTA>10小时。

核心结论

  • 群体药代动力学分析结合蒙特卡洛模拟识别出可在短程和长程结直肠手术中维持SSI相关病原体PTA的预防抗生素方案。

研究设计与样本

  • 在20例接受结直肠手术的患者中开展研究,患者接受一或两剂阿莫西林1000 mg、甲硝唑500 mg和庆大霉素3 mg/kg理想体重(按身高分带)。
  • 给药后至7小时测量抗生素浓度,每患者中位5个浓度(范围3–6)。
  • 采用NONMEM进行群体药代动力学分析,并对不同给药方案进行蒙特卡洛模拟以估算PTA。

主要发现

  • 所有抗生素的CL和V与体重相关,庆大霉素CL还与CLCR相关。
  • 所给剂量对咽峡炎链球菌组维持所需PTA至8小时,但对肠球菌、脆弱拟杆菌组、MSSA和大肠埃希菌未维持。
  • 阿莫西林每4小时追加500 mg足以达到多数相关病原体的PTA,但感染性心内膜炎风险患者需每2小时给药。
  • 体重>85 kg的患者甲硝唑剂量需1000 mg。
  • CLCR>50 mL/min的患者,庆大霉素5 mg/kg(手术延长至6小时时追加2.5 mg/kg)可维持PTA目标>10小时。

关键数值与推荐

  • 阿莫西林基础剂量1000 mg,每4小时追加500 mg可覆盖多数相关病原体;感染性心内膜炎风险者需每2小时给药。
  • 甲硝唑500 mg对体重≤85 kg患者适用,体重>85 kg者需1000 mg。
  • 庆大霉素3 mg/kg理想体重为基础方案;CLCR>50 mL/min者5 mg/kg可维持PTA>10小时,手术延长至6小时追加2.5 mg/kg。

临床怎么用

  • 结直肠手术预防用药需考虑体重和肾功能调整剂量,尤其甲硝唑在>85 kg患者需增量。
  • 对感染性心内膜炎风险患者,阿莫西林需每2小时给药以维持PTA。
  • CLCR>50 mL/min患者可考虑庆大霉素5 mg/kg,长程手术6小时追加2.5 mg/kg。

局限性

  • 研究样本量较小(20例患者),每患者中位5个浓度。
  • 蒙特卡洛模拟基于药代动力学参数和PTA目标,未提供临床结局数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate amoxicillin, metronidazole and gentamicin dosage regimens for antibiotic prophylaxis in colorectal surgery. METHODS: The study was conducted in 20 patients undergoing colorectal surgery. Patients received one or two doses of amoxicillin 1000 mg, metronidazole 500 mg and gentamicin 3 mg/kg ideal body weight, banded by height. Antibiotic concentrations were measured up to 7 h post dose. Population pharmacokinetic (PopPK) analysis with NONMEM followed by Monte Carlo simulation of different dosage regimens was used to estimate the PTA for potential organisms associated with surgical site infections (SSIs). RESULTS: A median of 5 (range 3-6) concentrations were available per patient. CL and V of all antibiotics were related to weight; gentamicin CL was also related to CLCR. The administered doses maintained the desired PTA up to 8 h for the Streptococcus anginosus group but not for enterococci, Bacteroides fragilis group, MSSA, and Escherichia coli. An additional 500 mg amoxicillin every 4 h was sufficient to achieve the PTA for most relevant organisms but 2 hourly dosing was required for patients at risk of infective endocarditis. A metronidazole dose of 1000 mg was required for patients >85 kg. In patients with CLCR >50 mL/min, 5 mg/kg gentamicin (with an additional 2.5 mg/kg in prolonged surgery at 6 h) maintained PTA targets for >10 h. CONCLUSIONS: PopPK analysis with Monte Carlo simulation identified prophylactic antibiotic regimens that would maintain the PTA for organisms associated with SSIs during short- and long-duration colorectal surgery.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. da Silva Neto MJJ, MacKay G, Agaram R, et al. Evaluation of amoxicillin, metronidazole and gentamicin dosage regimens for use in antibiotic prophylaxis in colorectal surgery. J Antimicrob Chemother. 2021. PMID: 34542630. doi:10.1093/jac/dkab337

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。